• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by Bruush Oral Care Inc.

    3/22/24 5:15:05 PM ET
    $BRSH
    Medical/Dental Instruments
    Health Care
    Get the next $BRSH alert in real time by email
    6-K 1 form6-k.htm

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 6-K

     

    Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934

     

    For the month of March 2024
       
    Commission File Number 001-41460

     

    Bruush Oral Care Inc.

    (Translation of registrant’s name into English)

     

    128 West Hastings Street, Unit 210

    Vancouver, British Columbia V6B 1G8

    Canada

    (844) 427-8774

    (Address of principal executive offices)

     

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

     

    Form 20-F ☒ Form 40-F ☐

     

    Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

     

    Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

     

     

     

     

     

     

    INFORMATION CONTAINED IN THIS FORM 6-K REPORT

     

    As previously reported on November 15, 2023 and February 27, 2024, Bruush Oral Care Inc. (the “Company”) received written notices from the Listing Qualifications Department of the Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that the Company no longer complied with the minimum bid price requirement and the low priced stocks rule for continued listing on the Nasdaq Capital Market. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share (the “Minimum Bid Price Requirement”), and Nasdaq Listing Rule 5810(c)(3)(A) provides that the Minimum Bid Price Requirement is not satisfied if the bid price for the listed securities is less than $1.00 per share for a period of 30 consecutive trading days. Nasdaq Listing Rule 5810(c)(3)(A)(iii) (the “Low Priced Stocks Rule”) provides that if, during any compliance period specified in Rule 5810(c)(3)(A), a company’s securities have a closing bid price of $0.10 or less for ten consecutive trading days, the Listing Qualifications Department shall issue a Staff Delisting Determination under Rule 5810 with respect to that security. As a result, Nasdaq has determined to delist the Company’s securities from the Nasdaq Capital Market (the “Determination”), and unless the Company requests an appeal of the Determination by 4:00 p.m. Eastern Time on March 5, 2024. On February 28, 2024, the Company requested a hearing before the Nasdaq Hearings Panel (the “Panel”), which automatically stays the suspension and/or delisting of the Company’s securities pending completion of the hearing and the expiration of any additional extension period granted by the Panel following the hearing. The hearing has been scheduled for April 25, 2024.

     

    On March 20, 2024, the Company received an additional staff determination (the “Determination”) from Nasdaq notifying the Company that because the Company is delinquent in filing its annual report on Form 20-F for the year ended October 31, 2023, this deficiency serves as an additional basis for delisting the Company’s securities from Nasdaq. The additional staff determination stated that the Company should present its views with respect to this additional deficiency to the Panel in writing no later than April 5, 2024. This deficiency will be considered by the Panel at the hearing scheduled for April 25, 2024. The Company plans to submit to the Panel a compliance plan with respect to the filing requirement by or before April 5, 2024. There can be no assurance as to the decision of the Panel.

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

          Bruush Oral Care Inc.
          (Registrant)
             
    Date: March 22, 2024   By: /s/ Aneil Singh Manhas
          Name: Aneil Singh Manhas
          Title: Chief Executive Officer

     

     

     

     

     

    Get the next $BRSH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BRSH

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BRSH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Brüush Receives Additional Delisting Notification to Address at Hearing

      VANCOUVER, BC / ACCESSWIRE / April 19, 2024 / Bruush Oral Care Inc. (NASDAQ:BRSH) (the "Company"), today announced that it received a notice (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market, LLC ("Nasdaq") on April 15, 2024 notifying the Company that because it is not compliant with Nasdaq's audit committee requirements as set forth in Listing Rule 5605 (the "Audit Committee Requirements"), this deficiency serves as an additional basis for delisting the Company's securities from Nasdaq. This deficiency will be considered by the Hearings Panel (the "Panel") at a hearing that has been scheduled for April 25, 2024 (the "Hearing") to address the Company's othe

      4/19/24 2:45:00 AM ET
      $BRSH
      Medical/Dental Instruments
      Health Care
    • Brüush Receives Additional Delisting Notification to Address at Hearing

      VANCOUVER, BC / ACCESSWIRE / March 25, 2024 / Bruush Oral Care Inc. (NASDAQ:BRSH) (the "Company"), today announced that it has received a notice from the Listing Qualifications Department of The Nasdaq Stock Market, LLC ("Nasdaq") on March 20, 2024 notifying the Company that because the Company is delinquent in filing its annual report on Form 20-F for the year ended October 31, 2023, this deficiency serves as an additional basis for delisting the Company's securities from Nasdaq per Listing Rule 5810(d). This deficiency will be considered by the Hearings Panel (the "Panel") at a hearing that has been scheduled for April 25, 2024 to address the Company's other current deficiencies.As previou

      3/25/24 6:00:00 PM ET
      $BRSH
      Medical/Dental Instruments
      Health Care
    • Brüush Receives Nasdaq Delisting Notification and Files to Appeal

      VANCOUVER, BC / ACCESSWIRE / March 1, 2024 / Bruush Oral Care Inc. (NASDAQ:BRSH) (the "Company"), today announced that it has received a notice (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market, LLC ("Nasdaq") on February 27, 2024 notifying the Company of Nasdaq's determination to delist the Company's common shares from The Nasdaq Capital Market because the Company's common shares had a closing bid price of $0.10 or less for ten consecutive trading days as of February 26, 2024, which triggered a notice of delisting pursuant to Nasdaq Listing Rule 5810(c)(3)(A)(iii) (the "Low Priced Stocks Rule").In addition to the Low Priced Stocks Rule delisting notice, as

      3/1/24 11:20:00 PM ET
      $BRSH
      Medical/Dental Instruments
      Health Care

    $BRSH
    SEC Filings

    See more
    • SEC Form 6-K filed by Bruush Oral Care Inc.

      6-K - Bruush Oral Care Inc. (0001913210) (Filer)

      6/20/24 9:00:44 PM ET
      $BRSH
      Medical/Dental Instruments
      Health Care
    • SEC Form 6-K filed by Bruush Oral Care Inc.

      6-K - Bruush Oral Care Inc. (0001913210) (Filer)

      4/18/24 5:25:04 PM ET
      $BRSH
      Medical/Dental Instruments
      Health Care
    • SEC Form 6-K filed by Bruush Oral Care Inc.

      6-K - Bruush Oral Care Inc. (0001913210) (Filer)

      3/22/24 5:15:05 PM ET
      $BRSH
      Medical/Dental Instruments
      Health Care

    $BRSH
    Financials

    Live finance-specific insights

    See more
    • Arrive Acquires AirBox Technologies in Advance of Brüush Merger

      Acquisition Broadens Patent Portfolio and Propels Arrive's Smart Mailbox as a Service CapabilitiesVANCOUVER, BC and INDIANAPOLIS, IN / ACCESSWIRE / December 18, 2023 / Bruush Oral Care Inc. (NASDAQ:BRSH) ("Brüush") announced today that its pending merger partner, Arrive Technology Inc. ("Arrive"), a technology company focused on facilitating the last inch of the last-mile for autonomous delivery, has acquired AirBox Technologies ("AirBox"). This acquisition includes AirBox's patent portfolio, which Arrive believes will broaden the capabilities of its high-tech mailbox system designed for autonomous and conventional package delivery. In addition to acquiring the patent portfolio, AirBox's CEO

      12/18/23 7:00:00 AM ET
      $BRSH
      Medical/Dental Instruments
      Health Care

    $BRSH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by Bruush Oral Care Inc. (Amendment)

      SC 13D/A - Bruush Oral Care Inc. (0001913210) (Subject)

      2/23/24 5:15:27 PM ET
      $BRSH
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13D/A filed by Bruush Oral Care Inc. (Amendment)

      SC 13D/A - Bruush Oral Care Inc. (0001913210) (Subject)

      2/16/24 5:15:16 PM ET
      $BRSH
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by Bruush Oral Care Inc. (Amendment)

      SC 13G/A - Bruush Oral Care Inc. (0001913210) (Subject)

      2/14/24 2:43:40 PM ET
      $BRSH
      Medical/Dental Instruments
      Health Care

    $BRSH
    Leadership Updates

    Live Leadership Updates

    See more
    • Brüush Appoints New Chief Financial Officer

      VANCOUVER, BC / ACCESSWIRE / April 4, 2023 / Bruush Oral Care Inc. (NASDAQ:BRSH) ("Brüush" or the "Company"), a direct-to-consumer leader in the oral care category, has appointed Mandeek Manhas as the new Chief Financial Officer, the Company announced today.With an extensive background in finance and accounting, Mr. Manhas brings over 17 years of experience to this role.Prior to joining Brüush, Mr. Manhas held leadership positions in two reputable organizations, including a private real estate company with over $2.5 billion in asset value and a publicly listed, multi-national mining company with advanced development stage and exploration projects. Mr. Manhas has also spent eleven years in au

      4/4/23 8:45:00 AM ET
      $BRSH
      Medical/Dental Instruments
      Health Care
    • PARVIS INVEST INC. AND GRAVITAS II CAPITAL CORP. RECEIVE CONDITIONAL APPROVAL OF REVERSE TAKEOVER TRANSACTION AND FILE FILING STATEMENT

      VANCOUVER, BC, March 2, 2023 /CNW/ - Gravitas II Capital Corp. ("Gravitas II") (TSXV:GII) and Parvis Invest Inc. ("Parvis") are pleased to announce that, in connection with their previously announced proposed business combination (the "Transaction") as described in Gravitas II's news releases dated November 3, 2022 and August 29, 2022, the TSX Venture Exchange Inc. (the "Exchange") has conditionally approved the Transaction and the listing of the common shares of Gravitas II, following closing of the Transaction (the "Resulting Issuer"). The Transaction is expected to close on March 3, 2023, following which the common shares of the Resulting Issuer are expected to begin trading under the sym

      3/2/23 7:57:00 AM ET
      $BRSH
      $GOOGL
      Medical/Dental Instruments
      Health Care
      Computer Software: Programming Data Processing
      Technology
    • Brüush Appoints New Vice President of Sales & Business Development

      Mark Humphrey will focus on expanding Brüush's distribution footprint into new channelsVANCOUVER, BC / ACCESSWIRE / November 3, 2022 / Bruush Oral Care Inc. (NASDAQ:BRSH), a direct-to-consumer leader in the oral care category, has appointed Mark Humphrey to the key role of Vice President - Sales & Business Development, the company announced today. Mr. Humphrey will help Brüush drive sales growth, with a particular focus on expanding the brand's distribution footprint into new channels and evaluating strategic partnerships with other companies.Mr. Humphrey brings over 20 years of experience in leadership positions at high-growth organizations, where he primarily focused on revenue generation.

      11/3/22 9:30:00 AM ET
      $BRSH
      Medical/Dental Instruments
      Health Care